11 Fanconi Anemia Clinical Trials in Detroit, MI (2026)

Q: How do I join a clinical trial in Detroit?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Detroit research site will contact you.

Recruiting Fanconi Anemia Studies in Detroit

NCT04077762Recruiting

Radial Vs. State-Of-The-Art Femoral Access for Bleeding and Access Site Complication Reduction in Cardiac Catheterization (REBIRTH)

This is a phase IV, prospective, open label, randomized-controlled study that will compare radial access with state-of-the-art femoral access in patients without ST-segment elevation acute myocardial ...

Detroit, MI3,266 participantsMinneapolis Heart Institute Foundation

View Study Details

NCT06964464Recruiting

Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator

This prospective, multicenter, open-label, randomized comparative effectiveness trial, titled CARVTOP-ICD, evaluates the impact of carvedilol versus metoprolol succinate in patients with heart failure...

Detroit, MI2,000 participantsUniversity of Rochester

View Study Details

NCT06994442Recruiting

Optimizing Pain Treatment in Children On Mechanical Ventilation

In this clinical trial, investigators want to learn more about using non-opioid pain medications for children with acute respiratory failure. Right now, doctors give these children opioids to help wit...

Detroit, MI644 participantsWeill Medical College of Cornell University

View Study Details

NCT06070428Recruiting

Project 4: ACHIEVE PATHFINDER

ACHIEVE-P4: PATHFINDER is a randomized, blinded clinical trial of portable air cleaners (PAC) provided at the time of hospital discharge to Heart Failure (HF) patients. It will be carried out at Henry...

Detroit, MI400 participantsHenry Ford Health System

View Study Details

NCT05330221Recruiting

Project 2: ACHIEVE- HF

This project is part of the ACHIEVE GREATER (Addressing Cardiometabolic Health In Populations Through Early PreVEntion in the GREAT LakEs Region) Center (IRB 100221MP2A), the purpose of which is to re...

Detroit, MI364 participantsHenry Ford Health System

View Study Details

NCT05784753Recruiting

HEART Camp Connect -Promoting Exercise in Adults With Heart Failure With Preserved Ejection Fraction

The goal of this study is to learn more about patients with heart failure with preserved ejection fraction (HFpEF) and exercise. Investigators want to see if meeting with a coach in person or by video...

Detroit, MI300 participantsUniversity of Nebraska

View Study Details

NCT06258447Recruiting

CardiAMP Heart Failure II Trial for Patients With Ischemic Heart Failure With Reduced Ejection Fraction

Concentrated autologous bone marrow mononuclear cells (ABM MNC) contain potentially therapeutic cell factors and past studies support therapeutic benefit to patients with cardiac diseases of acute myo...

Detroit, MI250 participantsBioCardia, Inc.

View Study Details

NCT06291922Recruiting

Home-Based Exercise Program Using Mobile Technology After Left Ventricular Assist Device Implantation

The goal of this clinical trial is to evaluate the effects of a home-based exercise program using mobile technology on physical activity and capacity, frailty and muscle mass, and quality of life in p...

Detroit, MI100 participantsUniversity of Pennsylvania

View Study Details

NCT05034432Recruiting

The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients

To investigate the effect of VTA ablation at the time of LVAD implant to see if it can reduce the incidence of VTA after surgery...

Detroit, MI100 participantsUniversity of Rochester

View Study Details

NCT05919680Recruiting

A Study of NST-6179 in Subjects With Intestinal Failure-Associated Liver Disease (IFALD).

This is a phase 2a, multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of NST-6179 in subjects with ...

Detroit, MI36 participantsNorthSea Therapeutics B.V.

View Study Details

NCT07054489Recruiting

UPBEAT: Using Polygenic Scores to Guide BB Therapy in HF With Mildly Reduced EF

This study will use polygenic scores, a tool which describes differences in genetics, to examine effectiveness of beta blocker medication in heart failure patients with ejection fraction of 41-50 perc...

Detroit, MI10 participantsDavid Lanfear

View Study Details

About Fanconi Anemia Clinical Trials in Detroit

Fanconi anemia is a rare genetic disorder that affects bone marrow, reducing production of all types of blood cells and increasing cancer susceptibility. It is associated with physical abnormalities and organ defects. Treatment includes blood transfusions, growth factors, and stem cell transplant.

There are currently 11 fanconi anemia clinical trials recruiting participants in Detroit, MI. These studies are seeking a combined 7,470 participants. Research is being sponsored by Minneapolis Heart Institute Foundation, University of Rochester, Weill Medical College of Cornell University and 6 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Fanconi Anemia Clinical Trials in Detroit — FAQ

Are there fanconi anemia clinical trials in Detroit?

Yes, there are 11 fanconi anemia clinical trials currently recruiting in Detroit, MI. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Detroit?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Detroit research site will contact you about next steps.

Are clinical trials in Detroit free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Detroit studies also compensate for your time and travel.

What fanconi anemia treatments are being tested?

The 11 active trials in Detroit are testing new therapies including novel drugs, biologics, and treatment approaches for fanconi anemia.

Data updated July 13, 2026 from ClinicalTrials.gov